Adjunctive Systemic Corticosteroids for Hospitalized Community-Acquired Pneumonia: Systematic Review and...

Area of Science:

• Pulmonology and Critical Care Medicine
• Pharmacology and Therapeutics

Background:

• Community-acquired pneumonia (CAP) is a significant cause of hospitalization.
• Previous studies on adjunctive corticosteroids for CAP have yielded conflicting results.
• Systemic corticosteroids are evaluated as an add-on therapy to antibiotics.

Purpose of the Study:

• To conduct a meta-analysis of randomized controlled trials (RCTs) evaluating the efficacy and safety of adjunctive systemic corticosteroids in hospitalized CAP patients.
• To resolve discrepancies in previous findings regarding corticosteroid treatment for CAP.

Main Methods:

• Systematic literature search of PubMed, Embase, and Cochrane databases for original RCTs published in English.
• Inclusion criteria: RCTs on hospitalized CAP patients treated with antibiotics and systemic corticosteroids.
• Meta-analysis using a random model with heterogeneity assessed by I(2) statistics.

Main Results:

• Ten RCTs with 1780 patients were included.
• Corticosteroids showed a trend towards reduced all-cause mortality in severe CAP (OR 0.41) and ICU subgroups (OR 0.21).
• Significant reductions observed in length of hospital stay (-0.98 days) and time to clinical stability (-1.16 days).

Conclusions:

• Adjunctive systemic corticosteroids appear to be a preferred strategy for hospitalized CAP patients.
• Benefits include shorter hospital stays and faster clinical stability.
• Serious complications did not significantly increase with corticosteroid use.